Summary by Moomoo AI
On December 9, 2024, Shanghai Fosun Pharma (Group) Co., Ltd. repurchased 0.306 million H shares on the Hong Kong Stock Exchange, accounting for 0.06% of the company's total issued H shares. The repurchase price range was HKD 14.1 to HKD 14.5, with a total amount of HKD 4.3636 million.The repurchased shares will be held as treasury shares, increasing the company's treasury stock to 6.64 million shares. This repurchase was conducted based on the authority granted at the shareholder meeting on June 26, 2024, allowing the company to repurchase up to 55.1941 million H shares. After this repurchase, the company has accumulated 1.2% of the authorized amount.According to relevant regulations, the company is prohibited from issuing new shares or selling or transferring treasury shares within 30 days after this repurchase (i.e., by January 8, 2025), unless approved by the Hong Kong Stock Exchange.
